Second Genome Launches Study of the Relationship Between Microbiome and Central Nervous System in Autism Spectrum Disorders

October 3, 2017,

Read More

Second Genome Named Technology Pioneer by World Economic Forum

June 4, 2017,

Read More

Second Genome Announces Appointments in Human Resources, Finance to Support Corporate Growth

December 7, 2016, South San Francisco, CA

Read More

Second Genome Partners with King’s College London to Evaluate the Influence of the Microbiome in Landmark EAT Study

October 11, 2016, South San Francisco, CA

Read More

Monsanto Collaborates with Second Genome to use Microbiome Technology Platform to Accelerate Protein Discovery

September 6, 2016, St. Louis, MO and South San Francisco, CA

Read More

Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer

July 13, 2016, South San Francisco, CA

Read More

Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund

April 20, 2016, South San Francisco, CA

Read More

Second Genome Announces Inflammatory Bowel Disease Research Alliance with the APC Microbiome Institute at University College Cork

April 27, 2015, South San Francisco, CA

Read More